Imugene, Ltd.Imugene, Ltd.Imugene, Ltd.

Imugene, Ltd.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪228.46 M‬USD
−0.0141USD
‪−99.78 M‬USD
0.00USD
‪6.29 B‬
Beta (1Y)
0.16

About IMUGENE LIMITED


CEO
Leslie Chong
Headquarters
Sydney
Founded
1986
ISIN
AU000000IMU9
FIGI
BBG002K3GXF0
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IUGNF is 0.0303 USD — it has increased by 1.93% in the past 24 hours. Watch Imugene, Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Imugene, Ltd. stocks are traded under the ticker IUGNF.
IUGNF stock has fallen by −7.90% compared to the previous week, the month change is a 13.06% rise, over the last year Imugene, Ltd. has showed a −56.65% decrease.
We've gathered analysts' opinions on Imugene, Ltd. future price: according to them, IUGNF price has a max estimate of 0.28 USD and a min estimate of 0.07 USD. Watch IUGNF chart and read a more detailed Imugene, Ltd. stock forecast: see what analysts think of Imugene, Ltd. and suggest that you do with its stocks.
IUGNF reached its all-time high on Nov 9, 2021 with the price of 0.4690 USD, and its all-time low was 0.0050 USD and was reached on Jul 5, 2019. View more price dynamics on IUGNF chart.
See other stocks reaching their highest and lowest prices.
IUGNF stock is 21.90% volatile and has beta coefficient of 0.16. Track Imugene, Ltd. stock price on the chart and check out the list of the most volatile stocks — is Imugene, Ltd. there?
Today Imugene, Ltd. has the market capitalization of ‪228.46 M‬, it has decreased by −5.05% over the last week.
Yes, you can track Imugene, Ltd. financials in yearly and quarterly reports right on TradingView.
Imugene, Ltd. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
IUGNF earnings for the last half-year are −0.01 USD per share, whereas the estimation was −0.01 USD, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.01 USD per share. See more details about Imugene, Ltd. earnings.
Imugene, Ltd. revenue for the last half-year amounts to ‪−1.03 M‬ USD, despite the estimated figure of 0.00 USD. In the next half-year revenue is expected to reach ‪2.34 M‬ USD.
IUGNF net income for the last half-year is ‪−53.97 M‬ USD, while the previous report showed ‪−46.78 M‬ USD of net income which accounts for −15.37% change. Track more Imugene, Ltd. financial stats to get the full picture.
No, IUGNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IUGNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Imugene, Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Imugene, Ltd. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Imugene, Ltd. stock shows the sell signal. See more of Imugene, Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.